GRI Bio Statistics
Share Statistics
GRI Bio has 727.36K
shares outstanding. The number of shares has increased by -1.53%
in one year.
| Shares Outstanding | 727.36K |
| Shares Change (YoY) | -1.53% |
| Shares Change (QoQ) | -0.32% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,189 |
| FTD / Avg. Volume | 0.61% |
Short Selling Information
The latest short interest is 251.56K, so 34.59% of the outstanding
shares have been sold short.
| Short Interest | 251.56K |
| Short % of Shares Out | 34.59% |
| Short % of Float | 35.65% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.31 and the forward
PE ratio is -0.17.
GRI Bio's PEG ratio is
0.
| PE Ratio | -0.31 |
| Forward PE | -0.17 |
| PS Ratio | 0 |
| Forward PS | 0.3 |
| PB Ratio | 0.64 |
| P/FCF Ratio | -0.3 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for GRI Bio.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.43,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.43 |
| Quick Ratio | 3.43 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-2,735,666.67 |
| Employee Count | 3 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -97.68% in the
last 52 weeks. The beta is -2.38, so GRI Bio's
price volatility has been lower than the market average.
| Beta | -2.38 |
| 52-Week Price Change | -97.68% |
| 50-Day Moving Average | 4.32 |
| 200-Day Moving Average | 9.82 |
| Relative Strength Index (RSI) | 40.56 |
| Average Volume (20 Days) | 360,841 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.23M |
| Net Income | -8.21M |
| EBITDA | -8.23M |
| EBIT | -8.23M |
| Earnings Per Share (EPS) | -55.21 |
Full Income StatementBalance Sheet
The company has 5.03M in cash and 119K in
debt, giving a net cash position of 4.91M.
| Cash & Cash Equivalents | 5.03M |
| Total Debt | 119K |
| Net Cash | 4.91M |
| Retained Earnings | -39.74M |
| Total Assets | 5.74M |
| Working Capital | 911K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -8.61M
and capital expenditures 0, giving a free cash flow of -8.61M.
| Operating Cash Flow | -8.61M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.61M |
| FCF Per Share | -46.98 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
